Formela Jean Francois

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
23-Apr-24 5:25 PM
View: 
Korro Bio, Inc. (KRRO) 22-Apr-24Grant 17,857$56.00$999,992.002%
1.12M to 1.14M
07-Nov-23 9:09 PM
View: 
Korro Bio, Inc. (KRRO) 03-Nov-23Grant 1,119,290----100%
0 to 1.12M
16-Jun-22 6:33 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 14-Jun-22Grant 5,197----248%
2.09K to 7.29K
14-Dec-21 8:29 PM
View: 
Ikena Oncology, Inc. (IKNA) 14-Dec-21Market Sale
Duplicate
5,959$14.00$83,426.00(< 1%)
5.02M to 5.02M
14-Dec-21 8:29 PM
View: 
Ikena Oncology, Inc. (IKNA) 13-Dec-21Market Sale
Duplicate
8,330$14.64$121,951.00(< 1%)
5.03M to 5.02M
14-Dec-21 8:29 PM
View: 
Ikena Oncology, Inc. (IKNA) 10-Dec-21Market Sale
Duplicate
11,989$15.03$180,195.00(< 1%)
5.04M to 5.03M
14-Sep-21 7:23 PM
View: 
Translate Bio, Inc. (TBIO) 14-Sep-21Market Sale (Planned) 2,055,060$38.00$78,092,400.00(100%)
2.06M to 0
2%
29-Jun-21 9:48 AM
View: 
Intellia Therapeutics, Inc. (NTLA) 28-Jun-21Market Sale 553,376$132.73$73,448,896.00(98%)
563.38K to 10.0K
(< 1%)
25-Jun-21 6:05 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 23-Jun-21Grant 2,094----100%
0 to 2.09K
15-Jun-21 9:51 AM
View: 
Intellia Therapeutics, Inc. (NTLA) 14-Jun-21Market Sale 170,779$87.37$14,921,300.00(13%)
1.3M to 1.13M
(< 1%)
15-Jun-21 9:51 AM
View: 
Intellia Therapeutics, Inc. (NTLA) 11-Jun-21Market Sale 30,946$85.23$2,637,480.00(2%)
1.33M to 1.3M
(3%)
30-Apr-21 8:55 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 29-Apr-21Market Sale 4,513$85.43$385,546.00(< 1%)
769.61K to 765.1K
6%
28-Apr-21 7:51 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 28-Apr-21Market Sale 131,926$85.56$11,287,900.00(15%)
901.54K to 769.61K
(2%)
28-Apr-21 7:51 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 27-Apr-21Market Sale 210,230$86.22$18,126,000.00(19%)
1.11M to 901.54K
(< 1%)
28-Apr-21 7:51 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 26-Apr-21Market Sale 806$84.93$68,453.60(< 1%)
1.11M to 1.11M
(3%)
07-Apr-21 2:14 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 05-Apr-21Market Sale 800$84.98$67,984.00(< 1%)
1.11M to 1.11M
6%
01-Apr-21 6:23 PM
View: 
Ikena Oncology, Inc. (IKNA) 30-Mar-21Conversion
Duplicate
4,750,360----2809%
169.1K to 4.92M
14-Dec-21 8:29 PM
View: 
Ikena Oncology, Inc. (IKNA) 30-Mar-21Purchase
Duplicate
125,000$16.00$2,000,000.003%
4.92M to 5.04M
01-Mar-21 1:59 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 26-Feb-21Market Sale 501,945$60.29$30,262,700.00(31%)
1.62M to 1.11M
(< 1%)
23-Dec-20 6:07 PM
View: 
Translate Bio, Inc. (TBIO) 22-Dec-20Market Sale (Planned) 82,565$25.07$2,069,870.00(3%)
2.78M to 2.7M
12%
23-Dec-20 6:07 PM
View: 
Translate Bio, Inc. (TBIO) 21-Dec-20Market Sale (Planned) 56,536$25.50$1,441,930.00(2%)
2.84M to 2.78M
13%
27-Aug-20 8:14 PM
View: 
Translate Bio, Inc. (TBIO) 27-Aug-20Market Sale 10,097$14.38$145,217.00(< 1%)
3.84M to 3.83M
(54%)
27-Aug-20 8:14 PM
View: 
Translate Bio, Inc. (TBIO) 26-Aug-20Market Sale 44,381$14.80$656,746.00(1%)
3.89M to 3.84M
(50%)
27-Aug-20 8:14 PM
View: 
Translate Bio, Inc. (TBIO) 25-Aug-20Market Sale 34,410$15.00$516,160.00(< 1%)
3.92M to 3.89M
(48%)
18-Jul-18 8:40 AM
View: 
Intellia Therapeutics, Inc. (NTLA) 16-Jul-18Market Sale 6,686$31.17$208,397.00(< 1%)
1.62M to 1.62M
(99%)
03-Jul-18 6:37 PM
View: 
Translate Bio, Inc. (TBIO) 02-Jul-18Conversion
Duplicate
3,832,010----4258%
90.0K to 3.92M
20-Jun-18 12:03 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 19-Jun-18Market Sale 6,686$27.96$186,908.00(< 1%)
1.84M to 1.84M
(122%)
17-May-18 10:47 AM
View: 
Intellia Therapeutics, Inc. (NTLA) 16-May-18Market Sale 6,686$25.04$167,389.00(< 1%)
2.06M to 2.06M
(148%)
22-Mar-18 1:43 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 20-Mar-18Market Sale 39,245$23.87$936,743.00(2%)
2.32M to 2.28M
(160%)
07-Nov-17 4:08 PM
View: 
Spero Therapeutics, Inc. (SPRO) 06-Nov-17Conversion 1,936,780----136%
1.42M to 3.36M
07-Nov-17 4:08 PM
View: 
Spero Therapeutics, Inc. (SPRO) 06-Nov-17Purchase
Duplicate
428,571$14.00$5,999,990.0013%
3.36M to 3.79M
11-Jul-17 5:40 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 11-Jul-17Market Sale
Duplicate
80,000$16.07$1,285,560.00(2%)
3.66M to 3.58M
(286%)
11-Jul-17 5:40 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 10-Jul-17Market Sale
Duplicate
40,000$16.17$646,888.00(1%)
3.7M to 3.66M
(284%)
11-Jul-17 5:40 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 07-Jul-17Market Sale
Duplicate
30,000$16.77$502,992.00(< 1%)
3.73M to 3.7M
(270%)
13-Mar-17 10:34 AM
View: 
Intellia Therapeutics, Inc. (NTLA) 10-Mar-17Market Sale
Duplicate
5,504$14.06$77,410.50(< 1%)
3.74M to 3.73M
(341%)
13-Mar-17 10:34 AM
View: 
Intellia Therapeutics, Inc. (NTLA) 09-Mar-17Market Sale
Duplicate
15,628$13.85$216,432.00(< 1%)
3.75M to 3.74M
(348%)
11-May-16 7:01 PM
View: 
Intellia Therapeutics, Inc. (NTLA) 11-May-16Conversion
Duplicate
4,429,790----100%
0 to 4.43M
12-Feb-14 3:01 PM
View: 
Zyla Life Sciences (ZCOR) 11-Feb-14Conversion
Duplicate
2,080,560$1.11$2,302,220.00674%
308.72K to 2.39M
12-Feb-14 3:01 PM
View: 
Zyla Life Sciences (ZCOR) 11-Feb-14Purchase
Duplicate
41,667$12.00$500,004.002%
2.39M to 2.43M
12-Feb-14 3:01 PM
View: 
Zyla Life Sciences (ZCOR) 11-Feb-14Exercise (in-the money or at-the-money)
Duplicate
30,000$0.00$30.001%
2.43M to 2.46M
24-Oct-12 9:05 PM
View: 
Nuvelo Inc. (ORKA) 22-Oct-12Grant
Duplicate
317,379$0.39$125,016.0025%
1.26M to 1.58M
06-Mar-12 3:28 PM
View: 
Horizon Pharma, Inc. (HZNP) 02-Mar-12Market Purchase 828,443$3.62$2,999,960.0029%
2.86M to 3.69M
436%
04-Aug-11 5:13 PM
View: 
Horizon Pharma, Inc. (HZNP) 02-Aug-11Conversion
Duplicate
2,163,510$1.69$3,653,590.0019%
11.23M to 13.4M
04-Aug-11 5:13 PM
View: 
Horizon Pharma, Inc. (HZNP) 02-Aug-11Market Purchase
Duplicate
369,814$9.00$3,328,330.003%
13.4M to 13.77M
116%
31-Mar-10 3:05 PM
View: 
Nuvelo Inc. (ORKA) 29-Mar-10Market Sale
Duplicate
140,000$7.56$1,058,400.00(9%)
1.48M to 1.34M
100%
02-Nov-06 3:29 PM
View: 
Achillion Pharmaceuticals, ... (ACHN) 31-Oct-06Conversion
Duplicate
1,968,670----100%
0 to 1.97M
31-May-06 10:00 PM
View: 
Nxstage Medical, Inc. (NXTM) 26-May-06Payment of Exercise 6,795$10.95$74,405.20(< 1%)
2.6M to 2.59M
(189%)
31-May-06 10:00 PM
View: 
Nxstage Medical, Inc. (NXTM) 26-May-06Exercise (in-the money or at-the-money) 10,434$7.13$74,394.40< 1%
2.59M to 2.6M
07-Feb-06 9:24 PM
View: 
SGX Pharmaceuticals, Inc. (SGXP) 06-Feb-06Conversion
Duplicate
2,068,400----496%
416.67K to 2.49M
03-Feb-06 11:18 AM
View: 
SGX Pharmaceuticals, Inc. (SGXP) 01-Feb-06Purchase
Duplicate
416,666$6.00$2,500,000.00100%
0 to 416.67K
(76%)